质子放疗与仅手术治疗的儿童脑肿瘤患者神经认知变化的前瞻性纵向比较
该前瞻性纵向研究比较了质子全中枢照射、质子局部放疗和仅手术治疗的儿童脑肿瘤患者长达6年的神经认知评分变化。结果显示,质子局部放疗组和仅手术组所有指数评分保持稳定,而质子全中枢照射组的WMI、PSI和FSIQ评分显著下降。结论认为质子全中枢照射是神经认知风险因素,质子局部放疗与无放疗的结局相似。
要点
- 质子局部放疗组和仅手术组在全部神经认知指数上随访期间评分稳定(所有P>0.05)。
- 质子全中枢照射组WMI、PSI和FSIQ评分显著下降(P分别为0.036、0.004、0.017),VCI和PRI稳定。
- 质子局部放疗与无放疗的神经认知结局相似,即使在对放疗敏感的认知域。
核心结论
- 质子局部放疗与神经认知功能稳定相关,结局与未接受放疗相似,即使在对放疗敏感的认知域。
- 质子全中枢照射是神经认知风险因素,与光子放疗研究结果一致。
研究设计与样本
- 前瞻性纵向研究,纳入2012年至2017年间治疗的93例儿童脑肿瘤患者,其中质子全中枢照射22例、质子局部放疗31例、仅手术40例。
- 患者接受每年一次的神经认知评估,随访至多6年,采用一般线性混合模型分析评分随时间的变化并校正显著协变量。
主要发现
- 质子局部放疗组和仅手术组在所有神经认知指数上评分随时间保持稳定(所有P>0.05)。
- 质子全中枢照射组WMI、PSI和FSIQ评分显著下降(P分别为0.036、0.004、0.017),VCI和PRI评分稳定(所有P>0.05)。
- 仅手术组胶质瘤比例更高(P<0.001),质子全中枢照射组幕下肿瘤更多(P=0.001)且总放疗剂量更高(P=0.004)。
- 治疗组在性别(51.6%为男性)、治疗时年龄(中位数9.7年)和随访时长(中位数2.9年)方面相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Proton radiotherapy (PRT) reduces the volume of normal tissue receiving radiation dose, which may lead to better neurocognitive outcomes. We examined change in neurocognitive scores over time in pediatric brain tumor patients treated with proton craniospinal irradiation (CSI), proton focal RT, or surgery only. METHODS: Patients received annual neurocognitive evaluations for up to 6 years. We examined Full Scale IQ (FSIQ), Verbal Comprehension Index (VCI), Perceptual Reasoning Index (PRI), Working Memory Index (WMI), and Processing Speed Index (PSI) scores. General linear mixed models examined change in scores over time by treatment group, adjusting for significant covariates. RESULTS: Scores from 93 patients treated between 2012 and 2017 (22 proton CSI, 31 proton focal, and 40 surgery only) were examined. Treatment groups were similar on gender (51.6% male), age at treatment (median = 9.7 y), and length of follow-up (median = 2.9 y). The surgery only group had proportionately more gliomas (P < 0.001), and the proton CSI group had more infratentorial tumors (P = 0.001) and higher total RT dose (P = 0.004). The proton focal and surgery only groups exhibited stable neurocognitive scores over time across all indexes (all P > 0.05). In the proton CSI group, WMI, PSI, and FSIQ scores declined significantly (P = 0.036, 0.004, and 0.017, respectively), while VCI and PRI scores were stable (all P > 0.05). CONCLUSIONS: Focal PRT was associated with stable neurocognitive functioning into survivorship. Outcomes were similar whether patients received focal PRT or no radiotherapy, even in neurocognitive domains known to be particularly radiosensitive. Proton CSI emerged as a neurocognitive risk factor, consistent with photon outcomes research.
引用
- Kahalley LS, Douglas Ris M, Mahajan A, et al. Prospective, longitudinal comparison of neurocognitive change in pediatric brain tumor patients treated with proton radiotherapy versus surgery only. Neuro Oncol. 2019. PMID: 30753584. doi:10.1093/neuonc/noz041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。